approval
saveDUREZOL (DIFLUPREDNATE) — FDA approval
community read0 votes
Sponsor: SANDOZ. Form: EMULSION. Route: OPHTHALMIC
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalDIFLUPREDNATE — FDA approvalJan 26, 2026 · 252d ago
- approvalDUREZOL (DIFLUPREDNATE) — FDA approvalJul 15, 2025 · 447d ago
- approvalDUREZOL (DIFLUPREDNATE) — FDA approvalJul 29, 2016 · 3720d ago
- approvalDUREZOL (DIFLUPREDNATE) — FDA approvalApr 11, 2016 · 3829d ago
- approvalDUREZOL (DIFLUPREDNATE) — FDA approvalMay 15, 2013 · 4891d ago
- approvalDUREZOL (DIFLUPREDNATE) — FDA approvalMar 22, 2013 · 4945d ago
- approvalDUREZOL (DIFLUPREDNATE) — FDA approvalNov 27, 2012 · 5060d ago
- approvalDUREZOL (DIFLUPREDNATE) — FDA approvalJun 13, 2012 · 5227d ago
same company · ±60 days · 6
- approvalJUBBONTI: JUBBONTI (DENOSUMAB-BBDZ) — FDA approvalOct 29, 2025
- approvalANASTROZOLE: ANASTROZOLE — FDA approvalOct 24, 2025
- approvalnatalizumab biosimilar: TYRUKO (NATALIZUMAB-SZTN) — FDA approvalOct 30, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalNov 6, 2025
- approvalHYRIMOZ: HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalOct 16, 2025
- approvalONDANSETRON — FDA approvalNov 13, 2025
comments(0)
5-min edit window · permanent after that